Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Stevenson

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Clinical Endocrinology|April 19, 2016
Effects of gender, age and menopausal status on serum apolipoprotein concentrationsPanagiotis Anagnostis, John C Stevenson, David Crook, et al.
Maturitas|August 5, 2020
Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptomsSophia Tsiligiannis, Bettina C Wick-Urban, Jan van der Stam, et al.
Drugs in Context|December 14, 2020
Progestogens as a component of menopausal hormone therapy: the right molecule makes the differenceJohn C Stevenson, Serge Rozenberg, Silvia Maffei, et al.
Current Pharmaceutical Design|June 1, 2020
Cardiovascular Complications in Patients with Turner's SyndromeEirini Kostopoulou, Julia K Bosdou, Panagiotis Anagnostis, et al.
Maturitas|March 26, 2015
Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractionsPanagiotis Anagnostis, John C Stevenson, David Crook, et al.
The Journal of Family Planning and Reproductive Health Care|April 2, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative ReanalysisSamuel Shapiro, Richard D T Farmer, Helen Seaman, et al.
The Journal of Family Planning and Reproductive Health Care|June 7, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogenSamuel Shapiro, Richard D T Farmer, Alfred O Mueck, et al.
The Journal of Family Planning and Reproductive Health Care|June 7, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogenSamuel Shapiro, Richard D T Farmer, Alfred O Mueck, et al.
European Heart Journal|August 11, 2006
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot StudyPeter Collins, Marcus Flather, Belinda Lees, et al.
Clinical Endocrinology|July 11, 2012
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolismNik Manassiev, Ian F Godsland, Anthony J Proudler, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Clinical Endocrinology|April 19, 2016
Effects of gender, age and menopausal status on serum apolipoprotein concentrationsPanagiotis Anagnostis, John C Stevenson, David Crook, et al.
Maturitas|August 5, 2020
Efficacy and safety of a low-dose continuous combined hormone replacement therapy with 0.5 mg 17β-estradiol and 2.5 mg dydrogesterone in subgroups of postmenopausal women with vasomotor symptomsSophia Tsiligiannis, Bettina C Wick-Urban, Jan van der Stam, et al.
Drugs in Context|December 14, 2020
Progestogens as a component of menopausal hormone therapy: the right molecule makes the differenceJohn C Stevenson, Serge Rozenberg, Silvia Maffei, et al.
Current Pharmaceutical Design|June 1, 2020
Cardiovascular Complications in Patients with Turner's SyndromeEirini Kostopoulou, Julia K Bosdou, Panagiotis Anagnostis, et al.
Maturitas|March 26, 2015
Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractionsPanagiotis Anagnostis, John C Stevenson, David Crook, et al.
The Journal of Family Planning and Reproductive Health Care|April 2, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative ReanalysisSamuel Shapiro, Richard D T Farmer, Helen Seaman, et al.
The Journal of Family Planning and Reproductive Health Care|June 7, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogenSamuel Shapiro, Richard D T Farmer, Alfred O Mueck, et al.
The Journal of Family Planning and Reproductive Health Care|June 7, 2011
Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogenSamuel Shapiro, Richard D T Farmer, Alfred O Mueck, et al.
European Heart Journal|August 11, 2006
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot StudyPeter Collins, Marcus Flather, Belinda Lees, et al.
Clinical Endocrinology|July 11, 2012
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolismNik Manassiev, Ian F Godsland, Anthony J Proudler, et al.
Pageof 10